Dear IABS Colleagues, Stakeholders, Supporters and Collaborators,

 2024, IABS is prepared for an eventful year, driven by the dedication or our volunteers who have confirmed meetings on crucial topics like Next Generation Sequencing, Vaccination Strategies for High Pathogenicity Avian Influenza,  Advancing Chemistry, Manufacturing and Control; Science and Statistics, and Veterinary use of Phages.  For those eager to participate, specifics regarding dates, venues, and agendas can be found on the IABS Website or through newsletter links.

In addition to the exciting agenda for 2024, IABS is undergoing leadership changes within its IABS European Union (EU) Affiliate with the election of Dr. Olivier Espeisse as it’s new President.

One of our greatest strengths is the ability to bring stakeholders together to develop innovative solutions for expanded accessibility to biological products and health tools, and I look forward to working with Olivier and all our members to mainting this level of excellence.

All the best, Rick Hill, IABS President